IDDI Experience in Orphan Drugs

IDDI, Your partner in Orphan Drugs

International Drug Development Institute (IDDI) has provided Biostatistics and eClinical Services for 38 clinical trials in orphan drugs.

When conducting clinical trials involving rare diseases, sponsors face medical, scientific and operational challenges. Studies in orphan diseases need a CRO with specific strategies regarding site selection, patient enrollment, and retention.

At IDDI, we understand those challenges and have the expertise to help you successfully develop drugs for patients with rare and extremely rare diseases. Check out our experience!

TO ACCESS THE FILE OF OUR TRIALS EXPERIENCE PLEASE FILL OUT THE FORM BELOW

Orphan drugs, rare diseases

IDDI Experience in Rare Diseases

To access the file of our experience in rare diseases, please fill out this form.

    By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

    I authorize IDDI to use my data to contact me for commercial purposes. More information
    Powered by Atypic ®

    IDDI